Time for a common standard for cost-effectiveness in Europe?

The European Journal of Health Economics - Tập 7 - Trang 223-224 - 2006
Bengt Jönsson1
1Center for Health Economics, Stockholm School of Economics, Stockholm

Tài liệu tham khảo

Weinstein MC, Stason WB (1976) Hypertension: a policy perspective. Harvard University Press, Cambridge

Eberhardt S, Stoklossa C, Von der Schulenburg JM (2005) Euromet 2004. The influence of economic evaluation studies on health care decision making. A European study. Amsterdam

NICE (The National Institute for Clinical Excellence) (2004) Guide to the methods of technology appraisal. (http://www.nice.org.uk/page.aspx?o=201974)

IQWIG. Methoden Version 2.0 (Draft from the 26th April 2006) (http://www.iqwig.de)

CADTH (Canadian Agency for Drugs and Technology) (2006) I Health. Guidelines for the economic evaluation of health technologies, 3rd edn. CADTH: http://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf

European Network for Health Technology Assessment. EUnetHTA, coordinates the efforts of 27 European countries including 24 Member States of the European Union in evaluating health technology in Europe. (http://www.eunethta.net)

The Pharmaceutical Forum, WG3 on “Relative effectiveness” may be such a forum which includes most stakeholders at the European level